In early-stage lung cancer, N1-TANs are mainly localised to the tumour periphery, where they secrete GM-CSF and IL-6 to activate cytotoxic T lymphocytes (CTLs), thereby mediating tumour suppression (21). The gene discussed is CSF2; the disease is lung carcinoma.